XB

X.T.L. Biopharmaceuticals

XTLB
TEL AVIV STOCK EXCHANGEHealth Care

Income Statement

Total Revenue$451K
Gross Profit$3K
Operating Income$-4.47M
EBITDA$-6.5M
EBIT$-6.5M
Pre-tax Income$0
Net Income$-6.37M

Balance Sheet

Net Cash$0
Cash Equivalent$1.14M
Total Debt$34.5K
Net Debt$34.5K
Book Value$3.02M
Book Value Per Share0.01

Key Ratios

Return on Equity (ROE)undefined
Return on Assets (ROA)undefined
Return on Invested Capital (ROI)undefined
Net Profit Marginundefined
Current Ratioundefined
Quick Ratioundefined
Long-Term Debt / Equityundefined
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...